| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 108.72B | 110.54B | 107.42B | 114.46B | 96.47B | 116.05B |
| Gross Profit | 10.56B | 10.50B | 9.71B | 8.74B | 4.81B | 7.14B |
| EBITDA | 3.68B | 3.98B | 3.82B | 3.34B | -383.00M | 2.08B |
| Net Income | 2.53B | 2.90B | 2.65B | 1.92B | -1.59B | 369.00M |
Balance Sheet | ||||||
| Total Assets | 80.00B | 80.67B | 80.62B | 79.67B | 82.19B | 84.47B |
| Cash, Cash Equivalents and Short-Term Investments | 27.63B | 20.96B | 26.23B | 27.90B | 27.05B | 22.38B |
| Total Debt | 674.00M | 952.00M | 1.17B | 1.15B | 1.18B | 6.59B |
| Total Liabilities | 35.84B | 36.21B | 38.45B | 41.83B | 46.61B | 47.15B |
| Stockholders Equity | 42.56B | 42.84B | 40.66B | 36.56B | 34.43B | 35.89B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.64B | -2.39B | 1.85B | 9.92B | -4.92B |
| Operating Cash Flow | 0.00 | -4.38B | -2.09B | 2.17B | 11.52B | -4.54B |
| Investing Cash Flow | 0.00 | -398.00M | -28.00M | -256.00M | -2.68B | 89.00M |
| Financing Cash Flow | 0.00 | -891.00M | -801.00M | -776.00M | -5.74B | 4.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥51.18B | 6.41 | ― | 3.97% | 2.85% | 317.62% | |
75 Outperform | ¥52.51B | 7.30 | ― | 3.78% | 11.81% | 52.35% | |
73 Outperform | ¥49.46B | 7.92 | ― | 1.96% | 2.55% | -14.37% | |
67 Neutral | ¥32.43B | 9.10 | ― | 2.04% | -3.21% | -45.14% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥72.53B | 7.46 | ― | 3.84% | -8.79% | ― | |
60 Neutral | ¥60.66B | 19.35 | ― | 1.57% | 11.01% | 231.83% |